Analysis of survival and prognosis of 298 gastric adenocarcinoma patients with no distant metastasis

Liu,Luguang; Hao,Hongbo; Zhao,Lijuan; Hu,Junxia; Si,Baocai

doi:10.3892/ol.2017.7202

Analysis of survival and prognosis of 298 gastric adenocarcinoma patients with no distant metastasis

Authors:
- Luguang Liu
- Hongbo Hao
- Lijuan Zhao
- Junxia Hu
- Baocai Si
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China
Published online on: October 17, 2017 https://doi.org/10.3892/ol.2017.7202
Pages: 7813-7816
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study investigated the survival and prognosis of 298 gastric adenocarcinoma patients with no distant metastasis. For analysis and comparison of the prognosis of patients, a retrospective analysis was performed in 298 patients with perfect clinical data and follow-up data who received the D2 resections for gastric cancer in Shandong Provincial Hospital Affiliated to Shandong University between January, 2005 and January, 2012, and were diagnosed as gastric adenocarcinoma with no distant metastasis in postoperative pathological examination. Among the gastric adenocarcinoma patients without distant metastasis, we found that differences of sex, age, differentiation and position of tumor had no statistical significance (P>0.05), while comparisons of the tumor diameter, regional lymphatic metastasis, vascular invasion and pathological TNM stages (pTNM; T for tumor, N for lymph node and M for metastasis) showed statistical significance (P<0.05). One-way analysis of variance (ANOVA) indicated the correlation between the prognosis of gastric adenocarcinoma patients and tumor diameter, regional lymphatic metastasis, vascular invasion and pTNM stages of patients (P<0.05). Multivariate analysis of Cox regression models was performed for discovering the factors associated with the prognosis of patients, and the results suggested that position of tumor (P=0.016), regional lymphatic metastasis (P=0.042), vascular invasion (P=0.021) and pTNM stage (P=0.009) were the independent risk factors affecting the prognosis of gastric adenocarcinoma patients. During 60-month follow-up, the median survival duration of gastric adenocarcinoma patients with no distant metastasis was 38 months, while the 5-year accumulate survival rate was 49.3%. The results indicated that in gastric adenocarcinoma patients without distant metastasis, tumor diameter, regional lymphatic metastasis, vascular invasion and pTNM stage are major indicators affecting the prognosis of patients.

View Figures

View References

1	Nam S, Chung JW and Yang JY: WNT5A correlates with clinicopathological characteristics in gastric cancer: A meta-analysis. Cell Physiol Biochem. 41:33–40. 2017. View Article : Google Scholar : PubMed/NCBI
2	Wang J, Liu J, Zhang G and Kong D: Individualized proximal margin correlates with outcomes in gastric cancers with radical gastrectomy. Tumour Biol. 39:10104283177110322017.PubMed/NCBI
3	Kim DH, Kim SM, Choi MG, Sohn TS, Bae JM and Kim S: Multiple primary malignancies in patients with multiple early gastric cancer. J Gastric Cancer. 17:154–161. 2017. View Article : Google Scholar : PubMed/NCBI
4	Son T, Kwon IG, Lee JH, Choi YY, Kim HI, Cheong JH, Noh SH and Hyung WJ: Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer. Oncotarget. Jun 28–2017.(Epub ahead of print).
5	Gui R, Tang H, Gao M, Liu J, Huang R, Zhao G, Ma J, Yi M, Liu F and Fu Y: Impact of perioperative blood transfusion on survival of patients undergoing laparoscopic gastrectomy for gastric cancer. J BUON. 22:396–402. 2017.PubMed/NCBI
6	Yu B and Xie J: Identifying therapeutic targets in gastric cancer: The current status and future direction. Acta Biochim Biophys Sin (Shanghai). 48:90–96. 2016.PubMed/NCBI
7	Spychała A, Nowaczyk P and Murawa D: Comparison of lymphatic system staging classifications in patients with gastric cancer. Pol Przegl Chir. 87:551–557. 2015.PubMed/NCBI
8	Qiu MZ, Wang ZQ, Zhang DS, Luo HY, Zhou ZW, Wang FH, Li YH, Jiang WQ and Xu RH: Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumour Biol. 32:509–514. 2011. View Article : Google Scholar : PubMed/NCBI
9	Petrelli F, Ghidini M, Barni S, Steccanella F, Sgroi G, Passalacqua R and Tomasello G: Prognostic role of primary tumor location in non-metastatic gastric cancer: A systematic review and meta-analysis of 50 studies. Ann Surg Oncol. 24:2655–2668. 2017. View Article : Google Scholar : PubMed/NCBI
10	Costa LB, Toneto MG and Moreira LF: Do proximal and distal gastric tumours behave differently? Arq Bras Cir Dig. 29:232–235. 2016. View Article : Google Scholar : PubMed/NCBI
11	Ahmad R, Setia N, Schmidt BH, Hong TS, Wo JY, Kwak EL, Rattner DW, Lauwers GY and Mullen JT: Predictors of lymph node metastasis in western early gastric cancer. J Gastrointest Surg. 20:531–538. 2016. View Article : Google Scholar : PubMed/NCBI
12	Lee JH, Kang JW, Nam BH, Cho GS, Hyung WJ, Kim MC, Lee HJ, Ryu KW, Ryu SW, Shin DW, et al: Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: A multi-institutional cohort study. Eur J Surg Oncol. 43:432–439. 2017. View Article : Google Scholar : PubMed/NCBI
13	Kim JJ, Song KY, Hur H, Hur JI, Park SM and Park CH: Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol. 35:409–414. 2009. View Article : Google Scholar : PubMed/NCBI
14	Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C and Lise M: Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: Analysis of a large European monoinstitutional experience. Ann Surg Oncol. 10:1077–1085. 2003. View Article : Google Scholar : PubMed/NCBI
15	Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Kosaka T, Ono HA, Otsuka Y, Akiyama H, Ichikawa Y, et al: Tumor diameter as a prognostic factor in patients with gastric cancer. Ann Surg Oncol. 15:1959–1967. 2008. View Article : Google Scholar : PubMed/NCBI
16	Ren K, Liu QQ, An ZF, Zhang DP and Chen XH: MiR-144 functions as tumor suppressor by targeting PIM1 in gastric cancer. Eur Rev Med Pharmacol Sci. 21:3028–3037. 2017.PubMed/NCBI
17	Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
18	Tokunaga M, Ito S, Yoshikawa T, Nunobe S, Fukagawa T, Misawa K, Cho H, Katai H, Sano T and Terashima M: Prognostic factors for survival in patients with pT1 N⁺ or T2-3 N0 gastric cancer in Japan. Br J Surg. 104:885–890. 2017. View Article : Google Scholar : PubMed/NCBI
19	Wen T, Wang Z, Li Y, Li Z, Che X, Fan Y, Wang S, Qu J, Yang X, Hou K, et al: A Four-Factor immunoscore system that predicts clinical outcome for stage II/III gastric cancer. Cancer Immunol Res. 5:524–534. 2017. View Article : Google Scholar : PubMed/NCBI
20	Wang Z, Zhang X, Hu J, Zeng W and Zhou Z: Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology. J Visc Surg. 152:357–361. 2015. View Article : Google Scholar : PubMed/NCBI
21	Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, et al: The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: A large retrospective study from Southern China. BMC Cancer. 15:3702015. View Article : Google Scholar : PubMed/NCBI